Provided by Tiger Trade Technology Pte. Ltd.

SUNHO BIO-B

6.390
0.000
Volume:- -
Turnover:- -
Market Cap:1.00B
PE:-10.25
High:6.390
Open:6.390
Low:6.390
Close:6.390
52wk High:8.600
52wk Low:3.800
Shares:157.00M
HK Float Shares:156.67M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.624
ROE:-15.95%
ROA:-9.81%
PB:1.84
PE(LYR):-10.25
PS:52102.02

Loading ...

Sunho Biologics (02898) Announces Monthly Return for January 2026

Bulletin Express
·
Feb 04

Sunho Biologics Appoints Jiang Xiaoling as CEO and Chief Scientific Officer

Reuters
·
Jan 26

BRIEF-Sunho Biologics Appoints Jiang Xiaoling As CEO

Reuters
·
Jan 23

SUNHO BIO-B (02899): Jiang Xiaoling Appointed as CEO and Chief Scientific Officer

Stock News
·
Jan 23

Sunho Biologics - Appoints Jiang Xiaoling as CEO

THOMSON REUTERS
·
Jan 23

Sunho Biologics CEO Steps Down

MT Newswires Live
·
Jan 20

盛禾生物-B(02898):殷刘松辞任执行董事、首席执行官兼首席科学官

Stock News
·
Jan 19

Sunho Biologics Inc - Yin Liusong Resigns as CEO and Executive Director

THOMSON REUTERS
·
Jan 19

Sunho Biologics CEO and Chief Scientific Officer Dr. Yin Liusong Resigns

Reuters
·
Jan 19

Sunho Biologics, Inc. (02898) Announces Monthly Return for November 2025

Bulletin Express
·
Dec 02, 2025

Sunho Biologics, Inc. (02898) Announces Monthly Return, Authorized Capital Maintained at USD 100,000

Bulletin Express
·
Nov 03, 2025

Sunho Biologics Reports 178% Increase in Other Income for First Half of 2025, Driven by Higher Interest Income

Reuters
·
Sep 26, 2025

SUNHO BIO-B (02898): Deloitte Resigns as Company Auditor

Stock News
·
Sep 15, 2025

Sunho Biologics Inc. Auditor Resigns Over Unresolved Audit Fee Dispute

Reuters
·
Sep 15, 2025

SUNHO BIO-B (02898) Reports Interim Results with Net Loss of RMB38.2 Million, Up 5.88% Year-on-Year

Stock News
·
Aug 29, 2025

Sunho Biologics Reports 6-Month Loss of RMB38.2 Million, Slight Increase from Previous Year

Reuters
·
Aug 29, 2025